Incentives and Equity: A Randomized Controlled Trial to Improve Glycemic Control in Socioeconomically Disadvantaged Patients With Diabetes
The Annals of Family Medicine · 2026
DOI: 10.1370/afm.240556 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Annals of Family Medicine, 2026. Verfasst von Ayelet Prigozin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Meuhedet Health Services, Jerusalem district, affiliated with the Hebrew University Faculty of Medicine, Jerusalem, Israel. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glycemic Control, Hypoglycemic Agents, Motivation. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetes mellitus
Abstract (Originalsprache)
PURPOSE Despite availability of effective diabetes medications, 27% of Israeli patients did not reach glycemic control goals in 2019. Financial hardship markedly impacts diabetes management. The American Diabetes Association recommends financial incentive initiatives as part of quality improvement programs. We investigated the impact of a conditional reduction in medication out-of-pocket costs vs standard payment on glycemic control. METHODS A total of 186 patients with uncontrolled type 2 diabetes were recruited from neighborhoods having low socioeconomic status and randomly assigned to an intervention group or a control group. Patients in the intervention group were offered a discount on drug expenses (up to 600 new Israeli shekels or US $156, distributed through vouchers redeemable at pharmacies) that was conditional on improved glycemic control. Patients in the control group paid for their medications as usual. RESULTS At baseline, study participants had a mean glycated hemoglobin (HbA1c) level of 9.1%. The mean reduction in HbA1c level at 6 months in per protocol analysis was 1.4% (95% CI, 1.1%-1.7%) in the intervention group and 0.7% (95% CI, 0.3%-1.0%) in the control group (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Meuhedet Health Services, Jerusalem district, affiliated with the Hebrew University Faculty of Medicine, Jerusalem, Israel.
- Braun School of Public Health, Hebrew University, Jerusalem, Israel.
- Clalit Health Services, Jerusalem district, affiliated with the Hebrew University Faculty of Medicine, Jerusalem, Israel matanc123@gmail.com.
- Faculty of Medicine, Hebrew University, Jerusalem, Israel.
- Regeneron Pharmaceuticals, Tarrytown, New York.
- Clalit Health Services, Jerusalem district, affiliated with the Hebrew University Faculty of Medicine, Jerusalem, Israel.
Zitieren
APA
Prigozin, A., Cohen, M. J., Mosenzon, O., Mendelovich, H., Natsheh, A., Shmueli, A., Tsur, A., & Lahad, A. (2026). Incentives and Equity: A Randomized Controlled Trial to Improve Glycemic Control in Socioeconomically Disadvantaged Patients With Diabetes. The Annals of Family Medicine. https://doi.org/10.1370/afm.240556
Vancouver
Prigozin A, Cohen MJ, Mosenzon O, Mendelovich H, Natsheh A, Shmueli A, et al. Incentives and Equity: A Randomized Controlled Trial to Improve Glycemic Control in Socioeconomically Disadvantaged Patients With Diabetes. The Annals of Family Medicine. 2026. doi:10.1370/afm.240556
BibTeX
@article{Prigozin2026,
author = {Prigozin, Ayelet and Cohen, Matan J and Mosenzon, Ofri and Mendelovich, Hila and Natsheh, Ahlam and Shmueli, Amir and Tsur, Anat and Lahad, Amnon},
title = {Incentives and Equity: A Randomized Controlled Trial to Improve Glycemic Control in Socioeconomically Disadvantaged Patients With Diabetes},
journal = {The Annals of Family Medicine},
year = {2026},
doi = {10.1370/afm.240556}
}
EUVIMED